Antioxidative activity of clove (syzygium aromaticum) oil administration in Middle cerebral artery occlusion (mcao) Models of acute focal cerebral ischemia by Jawed, Hira et al.
Masthead Logo Pakistan Journal of Neurological Sciences (PJNS)
Volume 14 | Issue 1 Article 9
3-2019
Antioxidative activity of clove (syzygium
aromaticum) oil administration in Middle cerebral
artery occlusion (mcao) Models of acute focal
cerebral ischemia
Hira Jawed
University of Karachi
Mufzala Shamim
University of Karachi
Sumera Sohail
University of Karachi.
Uzma Firdous
University of Karachi.
Nazish Iqbal Khan
University of Karachi.
Follow this and additional works at: https://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Jawed, Hira; Shamim, Mufzala; Sohail, Sumera; Firdous, Uzma; and Iqbal Khan, Nazish (2019) "Antioxidative activity of clove
(syzygium aromaticum) oil administration in Middle cerebral artery occlusion (mcao) Models of acute focal cerebral ischemia,"
Pakistan Journal of Neurological Sciences (PJNS): Vol. 14 : Iss. 1 , Article 9.
Available at: https://ecommons.aku.edu/pjns/vol14/iss1/9
ABSTRACT
Objective: Stroke is a multifactorial neurological deficit syndrome. Oxidative stress is the principal underlying 
pathophysiological mechanism of ischemic stroke associated with neuronal damage and neuroinflammation.
Methodology: The purpose of present study is to investigate the preventive effects of clove (Syzygium aromaticum) oil 
pre-stroke and post-stroke administration against cerebral ischemia/reperfusion injury. Total of forty Wistar rats were 
divided into five groups as control, sham, stroke, pre-stroke treated (receive clove oil (33mg/kg body weight) for 15 
days once daily, stroke given after completion of 15 days pretreatment regime) and post-stroke treated group (receive 
two doses of clove oil (33mg/kg body weight) one at 0 h (immediately after stroke induction) and second dose after 6 
h of stroke). Stroke was induced via middle cerebral artery occlusion method (MCAO) (15 minutes occlusion followed 
by 24 h reperfusion). At end of experimentation, animals were tested for sensorimotor functioning via neurological 
deficit score and brain antioxidants including superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH) were 
estimated in all groups
Results: Results showed significant betterment in neurological deficit score in treated groups (P<0.05) compared to 
stroke group. MCAO induction significantly (P<0.01) increase oxidative stress in brain tissue of stroke group. 
Pre-stroke and post-stroke treatment regime significantly (P<0.05) enhance brain endogenous antioxidants (SOD, 
CAT, and GSH).
 
Conclusion: Suggesting the possible preventive role of clove oil against oxidative neuronal damage in acute focal 
cerebral ischemia.
Keywords: Oxidative stress, eugenol, antioxidants, clove oil, neurological deficit, stroke.
O R I G I N A L  A R T I C L E
INTRODUCTION: 
Cerebrovascåular accidents are highly prevalent global 
problem. Stroke is the fourth most common cause of 
death and second most leading cause of disability 
around the globe (1). Among other forms of stroke, 
ischemic stroke accounts for the majority (approx. 
85%) of all stroke cases. Stroke is the focal 
neurological deficit syndrome results from interrupted 
cerebral blood flow (CBF) with subsequent oxygen and 
glucose deprivation in nervous tissue (2). Reperfusion in 
ischemic tissue results in free radicals generation which 
augments neuronal injury followed by initiation of 
inflammatory mechanism (3). Uncontrolled calcium 
influx, glutamate excitotoxicity, reactive oxygen species 
(ROS) over production are the underlying 
pathophysiological mechanisms of ischemic stroke (4). 
Among all pathophysiological mechanisms of ischemic 
stroke, ROS over-production crucially contributes to 
neuronal oxidative burden, disruption of blood brain 
barrier, neuroinflammation and activation & recruitment 
of immune mediators in ischemic tissue (5,6). The only 
approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
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Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
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Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
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Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
 
Neurological Deficit Score 
Control Sham Stroke Pre-Treated Post-Treated 
0 0 7.83±1.06 4.83±1.07** 5.83±1.2*/NS 
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Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
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Experimental Groups
Effect of Clove Oil on Neurological Deficit Score
 
Control (n=8) Sham (n=8) Stroke (n=8) Pre-Treated (n=8) Post-Treated (n=8) 
Organ Weight (g) 2.015±0.21 2.04±0.23NS 2.29±0.15NS/NS 2.07±0.24NS/NS/NS 2.14±0.24NS/NS/NS/NS 
Total Protein (g/dL) 5.19±0.28 5.16±0.23NS 5.27±0.27NS/NS 5.07±0.25NS/NS/NS 5.15±0.27NS/NS/NS/NS 
SOD (U/g tissue) 73.99±6.64 71.94±5.99NS 50.842±2.89*/* 63.65±1.69NS/NS/** 59.89±2.01NS/NS/*/NS 
CAT ( mol/g tissue) 20.36±1.81 20.53±1.66NS 13.79±1.05*/* 18.807±0.86NS/NS/** 15.38±1.78NS/NS/NS/NS 
GSH (U/g tissue) 0.084±0.006 0.083±0.005NS 0.056±0.004**/** 0.077±0.006NS/NS/* 0.067±0.006NS/NS/NS/NS 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 4  ( 1 )   J A N U A R Y- M A R C H  2 0 1 9
 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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approved stroke therapy is recombinant tissue 
plasminogen activator (rtPA) but it has very narrow 
therapeutic window with high risk of thrombolysis limits 
its clinical use (7). 
Dietary antioxidants and antioxidant therapies has been 
long investigated for their promising neuroprotective, 
neuronal survival and restorative potentials(8). 
Clove (Syzygium aromaticum), an aromatic flower buds 
harvest from tree belongs of Myrtaceae family. Cloves’ 
essential oil (aromatic, pale yellowish fluid) extracted 
via distillation from air-dried, un-opened flower buds(9). 
For centuries, clove flowers, buds and essential oil of 
clove have been used in traditional medicinal systems 
to treat variety of health problems. 
A single clove bud contains 14-20% of essential oil. 
Eugenol is a principal bioactive phytochemical richly 
found in clove oil(10). Therapeutic potentials of clove are 
credited to eugenol including analgesic, 
anti-spasmodic, antioxidant, anti-inflammatory, 
anti-thrombotic, neuroprotective, anti-convulsant, 
anti-carcinogenic, anti-diabetic, anti-bacterial and 
antifungal properties(9,10). 
Therefore, the present study aimed to investigate the 
antioxidative and possible neuroprotective effects of 
clove (Syzygium aromaticum) oil administration against 
ischemia-reperfusion (IR) injury in middle cerebral 
artery occlusion (MCAO) rat models of acute focal 
cerebral ischemia.
 
MATERIALS & METHODS:
Ethics Statement: Animal handling, care and all 
experimental procedures were performed according to 
the guidelines of animal care and use (11).
 
ANIMALS:
Adult female Wistar rats (200-250g) were purchased 
from animal care facility of ICCBS, university of Karachi, 
Karachi Pakistan. 
Wistar Adult Female Rats (200-250gms) were used in 
all the experimental groups, purchased from the animal 
house of ICCBS Karachi, Pakistan. 
Animals were housed as one animal per cage in a 
well-aired room (12h light/dark cycles) with food 
(standard laboratory diet) and water ad libitum. Animals 
were allowed to acclimatize for a week prior to any 
experimentation.
CLOVE OIL:
Commercially available analytical grade Clove Oil 
(catalog no. C8392) was purchased from 
Sigma-Aldrich (St Louis, MO, USA).
Experimental Protocol:
A total of forty animals were randomly divided into 
following groups:
Control Group: (n=8) Normal, untreated animals.
Stroke Group (n=8): Stroke inducted group
Stroke Induction: Focal acute cerebral ischemia was 
established via MCAO technique as mentioned earlier 
(12). Briefly, following anesthesia (via ketamine 
(50mg/kg body weight) + xylazine (10mg/kg 
bodyweight) intraperitoneal injection) neck incision was 
made to expose common carotid artery (CCA), external 
carotid artery (ECA) and internal carotid artery (ICA). A 
silicon coated 4/0 nylon filament was introduce in left 
ECA to the lumen of ICA and advanced until it occluded 
the origin of middle cerebral artery (MCA). Filament was 
removed after 15 minutes to allow reperfusion (24 h). 
To maintain body temperature animal was placed on 
heating pad and carefully monitored throughout the 
procedure. 
Sham Group (n=8): Sham operated group.
Sham surgery: Sham group animals also underwent 
identical MCAO procedure but without the occlusion of 
MCA
Pre-stroke Treated Group (n=8): Animals of this 
group were intraperitoneally administered with clove oil 
(33mg/kg body weight per day) for 15 days. After the 
pre-treatment period, animals were inducted with 
stroke. 
Post-stroke Treated Group (n=8): Animals of this group 
received two intraperitoneal doses of clove oil 
(33mg/kg body weight i.p). First dose was administered 
immediately after stroke induction and second dose 
was administered 6 hours of stroke induction.
At the end of experimentation period (after 24 h of 
reperfusion), neurological deficit score and brain tissue 
antioxidants (superoxide dismutase, catalase and 
glutathione) were investigated in all groups
NEUROLOGICAL ASSESSMENT
Neurological deficits were evaluated 24 h after 
reperfusion according the methods as described earlier 
(13,14). The neurological deficit (ND) score comprised 
of three tests: body twisting, forelimb flexion and body 
balance as described earlier (15).
 
Final ND score was calculated as follow: ND score= 
score of Test 1 + Test 2 + Test 3
ND score rates neurological deficit on a scale of 0-9 
where 0, no deficit and 9 maximum neurological deficit.
Biochemical Assessment and Analytical 
Procedures
Tissue Sample
Under deep anesthesia brain was removed immediately 
rinsed with ice-cold saline (0.9% NaCl) weighed and 
stored at -80ºC till further investigation.
Preparation of Brain Tissue Homogenate:
Brain tissue homogenate was prepared according to 
the method as described in previous study (5).
Assessment of Brain Antioxidants:
Brain tissue antioxidants including superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
(GSH) was estimated according to the recommended 
procedures. 
Superoxide Dismutase Assay: Tissue SOD 
concentration was estimated spectrophotometrically by 
the method of Kono (16) based on nitroblue 
tetrazolium (NBT) reduction rate recorded at 560nm 
using Schimadzu UV spectrophotometer. SOD activity 
was expressed as U/g of tissue. Catalase Assay: 
Concentration of catalase in brain tissue was 
determined by the spectrophotometric procedure as 
mentioned by Sinha, 1972. The reaction mixture 
comprised of hydrogen peroxide and dichromate acetic 
acid solution and read at 570nm wavelength. Tissue 
CAT activity was recorded as µmol/g of tissue.
Glutathione Assay: GSH activity in brain tissue was 
estimated according to previously described method 
(18). GSH concentration was recorded on kinetic 
spectrophotometer at 25ºC and results were 
represented as U/g of tissue.
Statistical Analysis:
Data were presented as mean ± SEM (standard error 
of mean) Statistical analysis was performed by one-way 
analysis of variance (ANOVA) with Tukey’s post hoc test 
using the Statistical Package for the Social Sciences 
(SPSS) 16.0 software (SPSS Inc., Chicago, IL, USA). 
Difference with P<0.05 was considered statistically 
significant.
RESULTS
Pre and Post Treatments with Clove Oil Reduces 
Neurological Functional Deficit in MCAO Rats In the 
present study, we investigate whether clove oil 
administration is neuroprotective against acute IR injury 
by using MCAO rat model and pre and post-treatment 
regimen. As shown in Figure 1, no neurological deficits 
were observed in control and sham operated animals. 
Whereas MCAO mediated IR injury significantly affect 
sensorimotor function as indicated by the highest 
neurological scores stroke group animals (ND 
score=7.83≈8, P<0.0001), after MCAO. Compared 
to stroke group, animals pretreated with clove oil for 15 
days showed a significant decrease in neurological 
deficit score (P<0.01) after MCAO. While ND score of 
animals post-treated with clove oil with two dose after 
stroke also exhibit significant (P<0.05) decrease in ND 
score when compared with stroke group (Table 1). 
Comparing with stroke ND score, pre-treated group 
showed more improvements then post-treated group. 
However, no statistically significant change was 
observed in pre and post-treated groups (P>0.05) 
(Figure1, Table 1).
Pre and Post Treatments with Clove Oil 
Ameliorates Oxidative stress in MCAO rats’ Brain 
Tissue Brain weights of all experimental groups remain 
close to baseline vale except a nonsignificant increase 
was observed in brain weights of MCAO stroke group 
compared to control (P>0.05). As shown in Table 2, 
MCAO mediated IR injury significantly decrease brain 
antioxidants including superoxide dismutase, catalase 
and glutathione activities when compared with animals 
of control (SOD and CAT P<0.05; GSH: P<0.01) and 
sham (SOD and CAT P<0.05; GSH: P<0.01) groups. 
Effect of Pretreatment Regimen: Per day i.p. clove oil 
administration at dose of 33mg/kg body weight for 15 
days found to significantly increase brain SOD 
(P<0.01) CAT (P<0.01) and GSH (P<0.05) 
concentrations when compared with MCAO untreated 
rats (Table 2).
Effect of Post-treatment Regimen: Intraperitoneal 
administration of clove oil doses one at 0 h and second 
at 6 h post-stroke induction improve brain antioxidant 
(CAT, SOD, GSH) status in animals of post-treated 
group (SOD: P<0.05) however these increase were not 
statistically significant for CAT and GSH (P>0.05) as 
compared to stroke group (Table 2). Moreover, 
pretreatment found to improve tissue antioxidants more 
effectively then post-stroke clove oil doses (Table 2).
Table 1: Effect of Clove Oil administration on 
Neurological Deficit Score among different 
experimental groups
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
stroke/compared with Pre-treated)
Figure 1: ND score comaprision among 
experimental groups
Table 2: Effect of Clove Oil Pre and Post Treatments on 
Brain organ weight, total protein and Antioxidants 
(SOD, CAT, and GSH) levels in MCAO Rats
Values are presented as mean±SEM. *P<0.05, 
**P<0.01, NS: non-significant (compared with 
control/compared with sham/compared with 
stroke/compared with Pre-treated).
DISCUSSION
The global stroke burden has been raised alarmingly in 
past few years equally affecting young and geriatric 
population and both genders. Moreover ischemic stroke 
is the second most leading cause of permanent 
disabilities in adult (19). Alteplase (rtPA) is the only 
available pharmacological therapy for ischemic stroke 
but it has its own therapeutic limitations. Post-stroke 
physical disabilities are matter of serious concern as 
most of the stroke victims suffer some degree of 
physical disability after stroke incident. Due to side 
effects and other pharmacological therapeutic 
tribulations, identification of effective and safe therapy 
from natural products for stroke or any other disease 
management is the current horizon of research. 
Bioactive components from herbal origin and plant 
polyphenols are multipotent therapeutic agent to treat 
several health ailments (20). 
The current study also designed to investigate the 
therapeutic potentials of clove oil administration 
against focal cerebral ischemia induced neuronal 
damage. To study the protective effects of clove oil 
against cerebral IR injury, we used MCAO intraluminal 
technique to reproduce acute focal cerebral ischemia in 
rats (15 min occlusion and 24 h reperfusion). During 
reperfusion phase of ischemic stroke, ROS 
overproduction plays crucial role in destructing brain’s 
anatomical regions (neuronal damage) and its 
associated sensorimotor dysfunction(15). 
In our study we evaluate the post stroke neurological 
function and effects of treatment regimens via 
neurological deficit score. ND score is a composite 
score to assess sensorimotor functioning in rodent 
models of ischemic stroke or other neurological 
damage. Results of present study showed that MCAO 
untreated rats score maximum ND score (Table 1) 
while neurological functioning get better with pre and 
post treatments with clove oil possibly attributable to 
antioxidative and anti-spasmodic potentials of eugenol 
(bioactive component of clove oil). A study reported 
that eugenol effectively protect cortical cells from 
oxidative damage, excitotoxicity and ischemic injury via 
modulation of N-methyl-D-aspartate (NMDA) receptors 
& superoxide radicals (21). 
Endogenous antioxidants like glutathione, SOD and CAT 
are necessary to maintain tissue oxidant/antioxidant 
balance and to protect tissues from ROS damage (5,8). 
Results of present study showed marked decrease in 
brain SOD, CAT and GSH concentrations in MCAO 
animals while 15 days clove oil pretreatment and two 
doses of clove oil post-stroke both treatments found to 
significantly improve the antioxidant status following 
stroke induction. Consistent to our results, several 
experimental studies also reported the potent 
antioxidative activity of eugenol against oxidative injury 
due to eugenol free radical scavenging capabilities(9). 
Study of Farias and colleagues reported that that 
eugenol and eugenol derivatives effectively inhibit 
protein and lipid peroxidation in liver and brain tissues 
(22). According to another study, eugenol effectively 
inhibiting oxygen glucose deprivation (OGD) and NMDA 
induced neurotoxicity by rapidly scavenging superoxide 
radicals and controlling calcium influx and neuronal 
apoptosis (23).
CONCLUSION:
In summary, results of the present study demonstrate 
the antioxidant mediated protective effects of clove oil 
treatments against IR injury in MCAO rat model of acute 
focal cerebral ischemia as exhibited by better 
neurological function and antioxidants activities. Clove 
oil or eugenol could be a preventive treatment of stroke 
however further detailed experimental studies at 
different doses are recommended.
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